Christo Paulo P, Greco Dirceu B, Aleixo Agdemir W, Livramento Jose A
Eduardo de Menezes Hospital, FHEMIG, Belo Horizonte, MG, Brazil.
Arq Neuropsiquiatr. 2005 Dec;63(4):907-13. doi: 10.1590/s0004-282x2005000600001. Epub 2005 Dec 15.
Plasma HIV RNA levels reflect systemic viral replication but in CNS it may occur relatively independent of systemic infection, yet clinical application of CSF HIV-1 RNA levels is less clear.
To compare CSF and plasma HIV-1 RNA levels of patients with different opportunistic neurological diseases to those without neurological disease, as well as to correlate these levels with the outcome of the disease and use of HAART.
97 patients who had lumbar puncture for routine work up of suspected neurological diseases, were divided in 2 groups: without neurological disease (23) and with neurological disease (74). NASBA was used for plasma and CSF HIV RNA.
Median CSF viral load was higher in toxoplasmic encephalitis, cryptococcal meningitis, HIV dementia and neurological diseases without a defined etiology when compared to patients without neurological disease. There was no difference between plasma viral load in patients with and without neurological diseases. Median viral load was higher in plasma and CSF among patients who died when compared to those successfully treated. CSF and plasma viral load were lower in patients with opportunistic diseases on HAART than without HAART.
CSF viral load was higher in patients with any neurological disease, but this difference was not present in plasma viral load, suggesting that neurological disease influences more the CSF than plasma compartments. Notwithstanding different neurological diseases were not possible to be differentiated by the levels of CSF HIV-1.
血浆中人类免疫缺陷病毒(HIV)RNA水平反映全身病毒复制情况,但在中枢神经系统(CNS)中,其可能相对独立于全身感染而发生,然而脑脊液(CSF)中HIV-1 RNA水平的临床应用尚不清楚。
比较患有不同机会性神经疾病的患者与无神经疾病患者的脑脊液和血浆HIV-1 RNA水平,并将这些水平与疾病结局及高效抗逆转录病毒治疗(HAART)的使用情况相关联。
97例因疑似神经疾病进行腰椎穿刺常规检查的患者被分为两组:无神经疾病组(23例)和有神经疾病组(74例)。采用核酸序列扩增技术(NASBA)检测血浆和脑脊液中的HIV RNA。
与无神经疾病的患者相比,弓形虫脑炎、隐球菌性脑膜炎、HIV痴呆以及病因不明的神经疾病患者的脑脊液病毒载量中位数更高。有无神经疾病患者的血浆病毒载量无差异。与成功治疗的患者相比,死亡患者的血浆和脑脊液病毒载量中位数更高。接受HAART治疗的机会性疾病患者的脑脊液和血浆病毒载量低于未接受HAART治疗的患者。
患有任何神经疾病的患者脑脊液病毒载量更高,但血浆病毒载量无此差异,这表明神经疾病对脑脊液的影响大于对血浆的影响。尽管无法通过脑脊液HIV-1水平区分不同的神经疾病。